본문 바로가기
경제/간밤의 미국과 세계 경제시황

테슬라 2020년 이후 최대 폭락으로 실적 부진에 12% 하락

by 똑똑이채널 2024. 7. 25.
728x90
반응형
SMALL

미국 주식 매도에 공포 지수 3개월 만에 최고치 기록

https://www.reuters.com/markets/us/fear-gauge-hits-three-month-high-us-stocks-sell-off-2024-07-24/

 

IBM 컨설팅 침체로 소프트웨어 및 AI 수요 증가로 상승세

https://www.reuters.com/technology/ibm-beats-quarterly-revenue-estimates-software-strength-ai-demand-2024-07-24/

 

나스닥은 2022년 이후 최악의 하루를 보내며 3.5% 이상 하락

https://finance.yahoo.com/news/stock-market-news-today-stocks-smoked-nasdaq-falls-over-35-in-worst-day-since-2022-after-tesla-alphabet-trigger-big-tech-sell-off-170849829.html

 

Stock market news today: Stocks smoked, Nasdaq falls over 3.5% in worst day since 2022 after Tesla, Alphabet trigger Big Tech se

Disappointing Alphabet and Tesla earnings have stirred up worries that Big Tech's power to fuel stock market gains is fading.

finance.yahoo.com

 

미국 경제 3분기 골디락스 조짐 보여

https://finance.yahoo.com/news/us-economy-showing-signs-of-goldilocks-to-start-third-quarter-145525449.html

 

US economy showing signs of 'Goldilocks' to start third quarter

The latest PMI report from S&P Global showed signs of slowing inflation pressures amid resilient economic growth.

finance.yahoo.com

 

테슬라 2020년 이후 최대 폭락으로 실적 부진에 12% 하락

https://www.cnbc.com/2024/07/24/tesla-shares-fall-8percent-in-premarket-trading-after-weaker-than-expected-earnings.html

 

Tesla shares close down 12% after earnings miss for biggest slump since 2020

Tesla shares dropped after the company reported second-quarter earnings that missed expectations.

www.cnbc.com

 

포드 대규모 실적 미달로 11% 폭락

https://www.cnbc.com/2024/07/24/ford-motor-f-earnings-q2-2024.html

 

Ford shares tumble 11% after massive earnings miss

The automaker increased its target for free cash flow but maintained its 2024 earnings guidance, disappointing some investors who had hoped for a hike.

www.cnbc.com

 

화이자 희귀 유전성 출혈 장애 치료제 임상 시험 성공

https://www.cnbc.com/2024/07/24/pfizers-gene-therapy-for-hemophilia-a-succeeds-in-late-stage-trial.html

 

Pfizer's gene therapy for rare genetic bleeding disorder succeeds in late-stage trial

The hemophilia A treatment could become the company's second gene therapy to enter the U.S. market after Beqvez, which was cleared in April for hemophilia B.

www.cnbc.com

 

728x90
반응형
LIST

댓글